Understanding cancer paves the way for its cure.

Lighthouse Biotech was founded in response to the need to provide oncological and pharmaceutical research easy access to cancer cells at any stage of the disease, to enable cutting-edge analysis with the goal of developing precision medicine.

With its system, Lighthouse Biotech offers pure, intact, viable, and individually isolated cancer cells at favorable times and costs compared to other systems, providing the best possible starting base for next-generation applications and investigations.



The combination of expertise in Medicine, Biology, Physics, and Engineering has made possible the development of a cutting-edge liquid biopsy system capable of accelerating the advancement of precision medicine.


The long-term goal of Lighthouse Biotech is to contribute to bringing the right drug to the right patient at the right time.

Competitive Advantage

Top quality of biological material

Top quality of biological material: The extracted cells are pure, viable, unaltered, and
individually isolated.

High efficiency

High efficiency: Automated system, with a significant reduction in time and costs

Exclusive data on the metabolism of cancer cells

Exclusive data on the metabolism of cancer cells: An indicator of their aggressiveness.


Impartiality: Results not subject to human error of interpretation

Value Proposition

To deliver the entire heritage of information from circulating tumor cells (CTCs), isolated
through liquid biopsy, at any moment, at sustainable costs.

To detect metabolically active CTCs

To individually isolate live CTCs

For unprecedented data

To empower research

lighthouse biotech
A common blood draw is performed on the patient.

Each cell is encapsulated in a micro-droplet.

The cells are incubated to allow them to metabolize.
An optical system measures the pH of the droplets IDENTIFIES AND ISOLATES the acidic
ones (tumoral).
The tumor cells that come out are single, viable, and unmarked.
The cells can be analyzed individually or used in culture and animal models.

Our Difference

Isolating single and viable CTCs at sustainable costs.

Our solution allows for the acquisition of updated and complete information at any stage of the disease, with unprecedented competitive advantages for oncological research and the development of targeted and effective treatments.

For any inquiries and to receive updates:

Art.13 D.Lgs. 196/03

Read Privacy Policy regarding data processing


Information Regarding Data Processing

When filling out the form, personal data (Name, Email Address) is requested, with which the user will subsequently be identified in order to send a response to the indicated email address, storing the data in its databases for the purpose of carrying out direct mail marketing activities. Personal data is processed in accordance with the principles of fairness, lawfulness, and transparency.

LIGHTHOUSE BIOTECH SRL ensures that the processing of data, whether with or without the use of electronic or automated means, will be carried out using tools suitable for guaranteeing the security and confidentiality of the data subject, through the use of appropriate procedures to prevent the risk of loss, unauthorized access, unlawful use, and dissemination, in compliance with the limits and conditions set by EU Regulation 2016/679. The personal data of website users who submit an information request via the contact form will be retained for the time strictly necessary to fulfill the request for the purposes outlined.

Rigenera Project

Read our news section to find out more!

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.